206 related articles for article (PubMed ID: 33663171)
1. [A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions].
Wang XT; Ji ZZ; Han F; Lyu B
Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):227-232. PubMed ID: 33663171
[No Abstract] [Full Text] [Related]
2. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
3. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
4. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
5. Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.
Yamaguchi Y; Nagata Y; Hiratsuka R; Kawase Y; Tominaga T; Takeuchi S; Sakagami S; Ishida S
Digestion; 2016; 93(1):13-8. PubMed ID: 26789514
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of two serological methods in screening gastric cancer and its precancerous condition].
Li MY; Zhang DQ; Lu X; Chen WC
Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):907-911. PubMed ID: 30486559
[No Abstract] [Full Text] [Related]
7. Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer.
Kishino T; Oyama T; Tomori A; Takahashi A; Shinohara T
Intern Med; 2020 Jun; 59(12):1473-1480. PubMed ID: 32188803
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of different serological methods in screening early gastric cancer].
Ni DQ; Lyu B; Bao HB; Jin HF; Zhao J; Xu Y; Huang X
Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):294-300. PubMed ID: 30917423
[No Abstract] [Full Text] [Related]
9. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study.
Dong Z; Zhang X; Chen X; Zhang J
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31414587
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program.
Hirai R; Hirai M; Otsuka M; Mitsuhashi T; Shimodate Y; Mouri H; Matsueda K; Yamamoto H; Mizuno M
J Gastroenterol; 2023 Sep; 58(9):848-855. PubMed ID: 37340218
[TBL] [Abstract][Full Text] [Related]
11. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
[TBL] [Abstract][Full Text] [Related]
13. [Precancerous conditions and lesions of the stomach].
Falt P; Hanousek M; Kundrátová E; Urban O
Klin Onkol; 2013; 26 Suppl():S22-8. PubMed ID: 24325159
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ABC (D) stratification for screening patients with gastric cancer.
Kudo T; Kakizaki S; Sohara N; Onozato Y; Okamura S; Inui Y; Mori M
World J Gastroenterol; 2011 Nov; 17(43):4793-8. PubMed ID: 22147980
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of group D patients with negative serum anti-Helicobacter pylori antibody and positive serum pepsinogen test in healthy Koreans.
Han YM; Chung SJ; Choi JM; Lee C; Kim JS
J Dig Dis; 2018 Sep; 19(9):529-539. PubMed ID: 30117281
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between Precancerous Gastric Lesions and Gastritis Using a Gastric Cancer Risk Stratification Model.
Murphy JD; Epplein M; Lin FC; Troester MA; Nichols HB; Butt J; Pan K; You W; Olshan A
Asian Pac J Cancer Prev; 2023 Mar; 24(3):935-943. PubMed ID: 36974548
[TBL] [Abstract][Full Text] [Related]
18. Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings: a large-scale retrospective cohort study.
Nagasaki N; Ito M; Boda T; Kotachi T; Takigawa H; Oka S; Tanaka S
BMC Gastroenterol; 2022 Jun; 22(1):299. PubMed ID: 35725370
[TBL] [Abstract][Full Text] [Related]
19. Screening, Monitoring, and Treatment of Precancerous Atrophic Gastritis in the Prospective Study for Seven Years.
Kotelevets SM; Chekh SA
Asian Pac J Cancer Prev; 2020 Feb; 21(2):331-336. PubMed ID: 32102507
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer.
Xiao M; Zhang Z; Liao G; Liu M; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):110-115. PubMed ID: 36800825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
